5111-13-7

Basic information

• Product Name: (1S,3R,4R,5S,8S)-8-benzyloxy-7-keto-3,4-isopropylidenedioxy-2,6-dioxabicyclo[3.3.0]octane
• Synonyms: (1S,3R,4R,5S,8S)-8-benzyloxy-7-keto-3,4-isopropylidenedioxy-2,6-dioxabicyclo[3.3.0]octane
• CAS NO: 5111-13-7
• Molecular Weight: 306.315
• Mol File: 5111-13-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (1S,3R,4R,5S,8S)-8-benzyloxy-7-keto-3,4-isopropylidenedioxy-2,6-dioxabicyclo[3.3.0]octane(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,3R,4R,5S,8S)-8-benzyloxy-7-keto-3,4-isopropylidenedioxy-2,6-dioxabicyclo[3.3.0]octane(5111-13-7)
• EPA Substance Registry System: (1S,3R,4R,5S,8S)-8-benzyloxy-7-keto-3,4-isopropylidenedioxy-2,6-dioxabicyclo[3.3.0]octane(5111-13-7)

Safety Data

• Hazardous Substances Data: 5111-13-7(Hazardous Substances Data)

Upstream product

• 14362-29-9 α-D-glucurono-γ-lactone 
• 100-39-0 benzyl bromide 
• 3067-56-9 D-glucurono-3,6-lactone acetonide 
• 81927-55-1 O-benzyl 2,2,2-trichloroacetimidate 

Downstream Products

• 5111-14-8 1,2-O-isopropylidene-5-O-benzyl-3-hydroxy-α-D-glucofuranosiduronamide 
• 133634-85-2 3,6-anhydro-5-O-benzyl-1,2-O-isopropylidene-6-C-methylene-α-D-glucofuranose 
• 1394245-90-9 C₃₉H₇₂O₉Si₄ 
• 864512-90-3 trans-caffeoyl-6-O-D-glucono-γ-lactone 
• 1394245-97-6 C₂₅H₃₂O₇ 
• 1394245-92-1 C₂₀H₂₂O₆ 
• 1394245-94-3 C₃₉H₇₂O₉Si₄ 
• 1394245-99-8 (5S)-epi-vittarilide A 
• 142719-12-8 C₂₂H₃₆O₆Si 
• 1394245-86-3 C₂₄H₄₀O₇Si 
• 1394245-87-4 C₂₅H₃₂O₇ 
• 1394245-89-6 C₂₀H₂₂O₆ 
• 94686-95-0 5,6-Di-O-benzyl-D-glucofuranose 

Relevant articles and documents

Synthesis of 1,3,4,6-Tetra-O-acetyl-l-gulose

A novel, practical and concise synthesis of 1,3,4,6-tetra-O-acetyl-l-gulose is described, using d-glucuronolactone as the starting material and other inexpensive and readily available agents (22% overall yield in 9 steps). With this method, the synthesis of l-gulose and the tumor-targeting disaccharide of BLMs can be more efficient and convenient.

An efficient and straightforward synthetic process to an amino sugar analogue, furanodictine B

A convenient and practical strategy for the construction of a natural amino sugar analogue, furanodictine B, isolated from the multicellular fruit body has been developed in an optically active form. The synthetic process is based on readily accessible and stereodefmed manipulation of the highly functionalized bicyclic derivative incorporating the glucuronolactone-derived skeleton.